Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-24 @ 5:40 PM
Study NCT ID:
NCT02726568
Status:
UNKNOWN
Last Update Posted:
2019-02-19
First Post:
2016-03-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Sponsor:
Betta Pharmaceuticals Co., Ltd.